Cargando…

Prednisolone is associated with a worse lipid profile than hydrocortisone in patients with adrenal insufficiency

OBJECTIVE: Prednisolone is used as glucocorticoid replacement therapy for adrenal insufficiency (AI). Recent data indicate that its use in AI is associated with low bone mineral density. Data on risk factors for cardiovascular disease in patients with AI treated with prednisolone are scarce, despite...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quinkler, Marcus, Ekman, Bertil, Marelli, Claudio, Uddin, Sharif, Zelissen, Pierre, Murray, Robert D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148794/ https://www.ncbi.nlm.nih.gov/pubmed/27864317 http://dx.doi.org/10.1530/EC-16-0081

Ejemplares similares

European Adrenal Insufficiency Registry (EU-AIR): a comparative observational study of glucocorticoid replacement therapy
por: Ekman, Bertil, et al.
Publicado: (2014)

Characterization of patients with adrenal insufficiency and frequent adrenal crises
por: Quinkler, Marcus, et al.
Publicado: (2021)

Prednisolone is associated with a worse bone mineral density in primary adrenal insufficiency
por: Frey, Kathrin R, et al.
Publicado: (2018)

THERAPY OF ENDOCRINE DISEASE: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe
por: Grossman, Ashley, et al.
Publicado: (2013)

Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study
por: Nilsson, Anna G, et al.
Publicado: (2017)

Early Metabolic Benefits of Switching Hydrocortisone to Modified Release Hydrocortisone in Adult Adrenal Insufficiency
por: Bannon, Christopher A. M., et al.
Publicado: (2021)

Optimising prednisolone or prednisone replacement in adrenal insufficiency
por: Sharma, Angelica, et al.
Publicado: (2023)

Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency
por: Nilsson, A G, et al.
Publicado: (2014)

Dual-release hydrocortisone vs conventional glucocorticoids in adrenal insufficiency
por: Guarnotta, V, et al.
Publicado: (2019)

Hydrocortisone/prednisolone: Various toxicities: case report
Publicado: (2021)

BclI polymorphism of the glucocorticoid receptor and adrenal crisis in primary adrenal insufficiency
por: Zopf, Kathrin, et al.
Publicado: (2017)

Metabolic Effects of Cortisone Acetate vs Hydrocortisone in Patients With Secondary Adrenal Insufficiency
por: Ekstrand, Elise, et al.
Publicado: (2020)

Bone safety of dual-release hydrocortisone in patients with autoimmune primary adrenal insufficiency
por: Bioletto, Fabio, et al.
Publicado: (2023)

Exenatide Alters Absorption of Hydrocortisone in a Diabetic Patient With Panhypopituitarism: Iatrogenic Adrenal Insufficiency
por: Fujita, Yukari, et al.
Publicado: (2013)

The use of prednisolone versus dual-release hydrocortisone in the treatment of hypoadrenalism
por: Choudhury, Sirazum, et al.
Publicado: (2021)

RF09 | PSAT70 Comparison of Prednisolone Versus Modified-release Hydrocortisone (Efmody) in the Treatment of Congenital Adrenal Hyperplasia (CAH)
por: Merke, Deborah P, et al.
Publicado: (2022)

Hydrocortisone malabsorption due to polyethylene glycols (Macrogol 3350) in a girl with congenital adrenal insufficiency
por: Stagi, Stefano, et al.
Publicado: (2014)

Tissue Glucocorticoid Metabolism in Adrenal Insufficiency: A Prospective Study of Dual-release Hydrocortisone Therapy
por: Dineen, Rosemary A, et al.
Publicado: (2023)

Hydrocortisone associated hypomania in a child responding to shifting back to prednisolone
por: Grover, Sandeep, et al.
Publicado: (2014)

Prednisolone has the same cardiovascular risk profile as hydrocortisone in glucocorticoid replacement
por: Smith, David J F, et al.
Publicado: (2017)

In Vitro Evaluation of Cocoa Pod Husk Pectin as a Carrier for Chronodelivery of Hydrocortisone Intended for Adrenal Insufficiency
por: Adi-Dako, Ofosua, et al.
Publicado: (2017)

SAT-391 Perioperative Glucocorticoid Therapy for Patients with Adrenal Insufficiency: Dosing Based on Hydrocortisone Pharmacokinetic Data
por: Rahhal, Marie-Noel, et al.
Publicado: (2019)

Health Care Burden in Patients With Adrenal Insufficiency
por: Gunnarsson, Candace, et al.
Publicado: (2017)

Dual-release hydrocortisone improves hepatic steatosis in patients with secondary adrenal insufficiency: a real-life study
por: Guarnotta, Valentina, et al.
Publicado: (2019)

A Prospective Study of Children Aged 0–8 Years with CAH and Adrenal Insufficiency Treated with Hydrocortisone Granules
por: Neumann, Uta, et al.
Publicado: (2020)

Effects of the therapy shift from cortisone acetate to modified-release hydrocortisone in a group of patients with adrenal insufficiency
por: Frigerio, Sofia, et al.
Publicado: (2023)

Benefits of dual-release hydrocortisone treatment on central adiposity and health-related quality of life in secondary adrenal insufficiency
por: Gasco, V., et al.
Publicado: (2022)

Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia
por: Merke, Deborah P, et al.
Publicado: (2021)

SAT-381 Cognitive Function and Quality of Sleep in Patients with Adrenal Insufficiency May Benefit by Therapy with Dual-Release Hydrocortisone
por: Krekeler, Clarissa, et al.
Publicado: (2019)

Glucocorticoid Replacement for Adrenal Insufficiency and the Development of Non-Alcoholic Fatty Liver Disease
por: Meyer, Gesine, et al.
Publicado: (2023)

MON-179 Association Between Long-Term Prednisolone Induced Adrenal Insufficiency and Polymorphisms in the Glucocorticoid Receptor Gene
por: Borresen, Stina Willemoes, et al.
Publicado: (2020)

A Prospective Cross-Over Study of Tissue Glucocorticoid Metabolism in Patients With Adrenal Insufficiency: The Effects of Dual-Release Hydrocortisone Therapy
por: Dineen, Rosemary Anne, et al.
Publicado: (2021)

RF09 | PSAT84 Management of Adrenal Insufficiency with Continuous Subcutaneous Hydrocortisone Infusion: Long-Term Experience in 27 Patients
por: Lalani, Atul, et al.
Publicado: (2022)

Adrenal insufficiency is common amongst kidney transplant recipients receiving maintenance prednisolone and can be predicted using morning cortisol
por: Tomkins, Maria, et al.
Publicado: (2022)

Somatosensory function in patients with secondary adrenal insufficiency treated with two different doses of hydrocortisone—Results from a randomized controlled trial
por: Werumeus Buning, Jorien, et al.
Publicado: (2017)

Adrenal Insufficiency
por: Marik, Paul Ellis
Publicado: (2014)

Comparison of Hydrocortisone Continuous Rate Infusion and Prednisolone or Dexamethasone Administration for Treatment of Acute Hypoadrenocortical (Addisonian) Crisis in Dogs
por: Mitropoulou, Athanasia, et al.
Publicado: (2022)

Giant bilateral adrenal lipoma in a patient with congenital adrenal hyperplasia
por: Kienitz, Tina, et al.
Publicado: (2021)

Nocturnal Dexamethasone versus Hydrocortisone for the Treatment of Children with Congenital Adrenal Hyperplasia
por: Dauber, Andrew, et al.
Publicado: (2010)

Switching From Immediate-Release to Fractionated Dual-Release Hydrocortisone May Improve Metabolic Control and QoL in Selected Primary Adrenal Insufficiency Patients
por: Delle Cese, Francesca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q1jni7qfmqc0rk18lujq491634